Calliditas Therapeutics(CALT) - 2024 Q1 - Quarterly Report
Calliditas Therapeutics(US:CALT)2024-04-25 20:06The success of the early access program exceeded our expectations. Without any sales representatives and despite the inconvenience of flying out to Hainan's Boao, there were approximately 700 patients signed up for the program. This strong demand underscores the urgent and significant unmet medical needs among the large IgAN patient base in China. received from nephrologists in China? How many sales people are you successful commercial launch of Nefecon? | --- | --- | --- | |-------------------------------- ...